Carl Berke, PhD, is a Partner at Mass General Brigham Ventures and has more than 25 years of experience in innovation management and bringing new technologies from the lab to the market. As a bench scientist and R&D director, he worked at Polaroid Corporation and Hygeia Sciences in the development of photographic and clinical products for both consumer and professional markets. He is an inventor on six U.S. patents. He served as a partner at Integral and Analysis Group, a consultancy focused on management of innovation and growth strategy. He has been an active private equity startup investor and is a founder of Mass Medical Angels.
Carl currently serves on the board for InStride Health, Pykus Therapeutics, SeQure Dx, Rippl Care and Lyndra Therapeutics. Previous board service appointments include Annovation, CardioSight, CodaMetrix, Combinent, InfoBionic, Kasalis, Life Image, QPID Health, Quosa, Sebacia, Starlight Cardiovascular, Syntimmune, and the Sudanese Education Fund.
Carl holds an AB degree from Cornell University and a PhD in organic chemistry from the University of California at Berkeley. He is also a lecturer at the MIT Sloan School of Management, teaching various courses on the topic of biomedical enterprise.